| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2012 | CN102552291A Vein medication preparation for fospropofol disodium, as well as preparation method and application of vein medication preparation |
| 07/11/2012 | CN102552290A Glimepiride medicinal composition tablets and preparation method and application thereof |
| 07/11/2012 | CN102552289A Composition for treating diabetes and preparation method |
| 07/11/2012 | CN102552288A Stable composite fat-soluble vitamin composition and preparation method thereof |
| 07/11/2012 | CN102552287A Skin percutaneous absorption drug of adjuvant-containing mometasone furoate and adjuvant-containing water |
| 07/11/2012 | CN102552286A Separation type aqueous suspension medicament used for treating dermatopathy and formed by mometasone furoate and adjuvant-containing water |
| 07/11/2012 | CN102552285A Application of schizandronic acid to preparation of medicines for preventing and treating hepatitis virus |
| 07/11/2012 | CN102552284A Application of ergosterol in preparation of tumor multidrug resistance reversing medicines |
| 07/11/2012 | CN102552283A Transdermal absorption drug for skin prepared from hydrocortisone butyrate containing adjuvant and water containing adjuvant |
| 07/11/2012 | CN102552282A Transdermal absorption medicament used for skins and comprising adjuvant-containing methylprednisolone aceponate and adjuvant-containing water |
| 07/11/2012 | CN102552281A Application of auriculatone in preparing medicine for preventing and treating liver injury |
| 07/11/2012 | CN102552280A Pharmaceutical applications of glycyrrhizic acid or salt and derivative thereof |
| 07/11/2012 | CN102552279A Pentacyclic triterpenoid compound and application of plant extract containing same |
| 07/11/2012 | CN102552278A Medicinal composition for enhancing solubility of slightly-soluble medicament tolvaptan |
| 07/11/2012 | CN102552277A Amlodipine, aliskiren and hydrochlorothiazide compound antihypertensive medicine |
| 07/11/2012 | CN102552276A Levoamlodipine, aliskiren and hydrochlorothiazide compound antihypertensive medicine |
| 07/11/2012 | CN102552275A Injection powder and injection preparation of cefoperazone sodium-tazobactam combination |
| 07/11/2012 | CN102552274A Application of moving point motor protein small molecular inhibitor to inhibition of tumor cell proliferation |
| 07/11/2012 | CN102552273A Composition containing epigallocatechin gallate and methotrexate |
| 07/11/2012 | CN102552272A Method for treating sepsis |
| 07/11/2012 | CN102552271A Use of quinazoline compounds in preparation of drug for resisting flaviviridae viruses |
| 07/11/2012 | CN102552270A Composition prepared by epigallocatechin gallate and 5-fluorouracil for inhibiting tumor cell proliferation |
| 07/11/2012 | CN102552269A Application of SBT as inhibitor of GSK-3beta |
| 07/11/2012 | CN102552268A Medicinal preparation containing crystal form a imatinib mesylate |
| 07/11/2012 | CN102552267A Application of tetramethylpyrazine to preparation of medicine for treating contrast-induced nephropathy |
| 07/11/2012 | CN102552266A Application of bisbenzylisoquinoline compound or pharmaceutically acceptable salt thereof in preparing medicine or healthcare product for improving sleep |
| 07/11/2012 | CN102552265A Medicinal composition containing epigallocatechin gallate and camptothecin |
| 07/11/2012 | CN102552264A Application of sanguinarine to preparation of ionizing radiation protective agent |
| 07/11/2012 | CN102552263A Methods of increasing endogenous erythropoietin EPO |
| 07/11/2012 | CN102552262A Methods of increasing endogenous erythropoietin EPO |
| 07/11/2012 | CN102552261A Methods of increasing endogenous erythropoietin EPO |
| 07/11/2012 | CN102552260A Medicine for treating chilblain |
| 07/11/2012 | CN102552259A Iloperidone inclusion compound included by beta-cyclodextrin and medicinal composition thereof |
| 07/11/2012 | CN102552258A Pharmaceutical composition containing repaglinide and preparation method of same |
| 07/11/2012 | CN102552257A Compound preparation containing ranitidine hydrochloride and troxipide and application thereof |
| 07/11/2012 | CN102552256A Ilaprazole enteric capsule and preparation method thereof |
| 07/11/2012 | CN102552255A Amlodipine, aliskiren and sartan compound antihypertensive medicine |
| 07/11/2012 | CN102552254A Application of bulleyaconitine A used as state-independent sodium ion channel blocker to analgesia |
| 07/11/2012 | CN102552253A Skin external agent for eliminating acnes |
| 07/11/2012 | CN102552252A Medicine preparation of temozolomide and preparation method thereof |
| 07/11/2012 | CN102552251A Pharmaceutical composition containing 17 amino acids |
| 07/11/2012 | CN102552250A Compound amino acid injection for livestock as well as preparation method and applications thereof |
| 07/11/2012 | CN102552249A Application of edaravone |
| 07/11/2012 | CN102552248A Application of levo-oxiracetam and oxiracetam in preparation of medicines for preventing or treating coma |
| 07/11/2012 | CN102552247A Composition of vitamin C and preparation method thereof |
| 07/11/2012 | CN102552246A Application of epoxidized diene as osteoclast differentiation inhibitor |
| 07/11/2012 | CN102552245A Composition containing epigallocatechin gallate and taxol for suppressing tumor cell proliferation |
| 07/11/2012 | CN102552244A Composition for inhibiting tumor cell proliferation by using epigallocatechin gallate and carboplatin |
| 07/11/2012 | CN102552243A Application of myricanol and/or myricanone in preparing antitumor drugs |
| 07/11/2012 | CN102552242A Application of nobiletin to preparation of medicament for treating allelgic asthma |
| 07/11/2012 | CN102552241A Application of formononetin in preparing medicine for preventing and treating airway inflammation and asthma |
| 07/11/2012 | CN102552240A Compound medicine composition for improving oral bioavailability of paclitaxel and application of compound medicine composition |
| 07/11/2012 | CN102552239A Method for preparing anti-inflammatory and anti-tumor active ingredient group from liquorice dregs and application of anti-inflammatory and anti-tumor active ingredient group |
| 07/11/2012 | CN102552238A New application of luteolin |
| 07/11/2012 | CN102552237A Medicine composition and health food for resisting liver fibrosis or cirrhosis |
| 07/11/2012 | CN102552236A Application of tanshinone I to treatment of microglia-mediated disease |
| 07/11/2012 | CN102552235A Application of eonurine-cysteine conjugate in preparing medicine used for treating ischaemic cardiomyopathy |
| 07/11/2012 | CN102552234A Meclofenoxate hydrochloride medicinal composition and method for preparing freeze-drying powder injection of meclofenoxate hydrochloride medicinal composition |
| 07/11/2012 | CN102552233A Application of methyl 3, 4-dihydroxybenzoate in preparation of medicaments for preventing and treating nerve degenerative diseases |
| 07/11/2012 | CN102552232A Effective fraction of Xiao Ban Xia Tang, and preparation method and application thereof |
| 07/11/2012 | CN102552231A Application of sodium oxamate in preparation of (fat mass and obesity) FTO enzyme inhibitor and weight-losing medicine |
| 07/11/2012 | CN102552230A Application of cajanus cajan stilbene acid in preparing medicinal preparation for preventing and treating bacterial infectious diseases and preparation method thereof |
| 07/11/2012 | CN102552229A Application of compound (E)-N-[2-(3,4-dimethoxyphenyl)ethyl]-3-phenylacrylamide in preparation for medicine resisting Alzheimer disease |
| 07/11/2012 | CN102552228A Application of vitamin K to preparation of pyruvate kinase inhibitor |
| 07/11/2012 | CN102552227A Application of shikonin derivatives to preparation of pyruvate kinase inhibitors |
| 07/11/2012 | CN102552226A Application of two naphthoquinone compounds in preparing antitumor medicaments |
| 07/11/2012 | CN102552225A Novel application of tetrahydrocurcumin |
| 07/11/2012 | CN102552224A Application of curcumin derivative C2 in anti-colon cancer medicaments |
| 07/11/2012 | CN102552223A Application of alpha-terpinenol to treatment of arthritis |
| 07/11/2012 | CN102552221A Tulobuterol patch and preparation method thereof |
| 07/11/2012 | CN102552218A Memantine hydrochloride capsule sustained-release preparation and preparation method for same |
| 07/11/2012 | CN102552217A Trimetazidine sustained release capsule and preparation method thereof |
| 07/11/2012 | CN102552214A Ilaprazole enteric capsule and preparation method thereof |
| 07/11/2012 | CN102552212A Soft capsule for improving cranial nerve function and preparation method thereof |
| 07/11/2012 | CN102552211A Preparation composite of agomelatine and preparation method thereof |
| 07/11/2012 | CN102552210A Entecavir capsule and preparation method thereof |
| 07/11/2012 | CN102552208A Daidzein solid dispersion micro-pill capsule and preparation method thereof |
| 07/11/2012 | CN102552207A Tiopronin enteric capsule prescription and preparation process thereof |
| 07/11/2012 | CN102552206A Medicinal composition with anti-inflammatory and analgesic effects |
| 07/11/2012 | CN102552205A Potassium citrate controlled-release tablet preparation and preparation method thereof |
| 07/11/2012 | CN102552204A Compound antituberculous coating core tablet and preparing method |
| 07/11/2012 | CN102552203A Pirfenidone tablet and preparation method thereof |
| 07/11/2012 | CN102552202A Method for preparing xanthan gum omeprazole intragastric retention floating sustained-release tablets |
| 07/11/2012 | CN102552201A Flaccid anemone rhizome saponin W3 oral sustained-release tablet and preparation method thereof |
| 07/11/2012 | CN102552200A Felodipine sustained-release tablets |
| 07/11/2012 | CN102552199A Bulleyaconitine a controlled release tablet |
| 07/11/2012 | CN102552198A Cefcapene pivoxil hydrochloride hydrate composition tablets |
| 07/11/2012 | CN102552197A Tablet containing febuxostat and preparation method of the tablet |
| 07/11/2012 | CN102552196A Spray-drying method for preparing metoprolol succinate sustained-release capsules |
| 07/11/2012 | CN102552194A Naproxcinod self-emulsifying dripping pills and preparation method thereof |
| 07/11/2012 | CN102552193A Andrographolide tablet and preparation method thereof |
| 07/11/2012 | CN102552192A Orally disintegrating tablet of sedative-hypnotic medicine and preparation method for same |
| 07/11/2012 | CN102552191A Orally disintegrating tablet of 5-HT receptor agonist and preparation method thereof |
| 07/11/2012 | CN102552190A Ilaprazole enteric coated tablet and preparation method thereof |
| 07/11/2012 | CN102552189A Preparation method of simethicone drop pill |
| 07/11/2012 | CN102552188A Agomelatine tablet and preparation method thereof, as well as coated tablet of agomelatine tablet and preparation method thereof |
| 07/11/2012 | CN102552187A Oral hydroxyl silk peptide nanoparticles and preparation method thereof |
| 07/11/2012 | CN102552186A Pantoprazole sodium freeze-dried powder injection and preparation method thereof |
| 07/11/2012 | CN102552185A 9-nitrocamptothecin mixed micelle freeze-dried powder injection and preparation method thereof |
| 07/11/2012 | CN102552183A Preparation method of potassium sodium dehydroaadroandrographolide succinate freeze-dried powder injection |